EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

High recent PrEP adherence with point‐of‐care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort

Brenda Gati Mirembe, Deborah Donnell, Meighan Krows, Zinhle Zwane, Elizabeth Bukusi, Ravindre Panchia, Cheryl Louw, Noluthando Mwelase, Pearl Selepe, Melissa Senne, Logashvari Naidoo, Rachel Chihana und 22 weitere

Journal of the International AIDS Society · 2024

DOI: 10.1002/jia2.26389 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the International AIDS Society, 2024. Verfasst von Brenda Gati Mirembe und 33 weiteren Autor:innen. Beteiligte Einrichtung: Makerere University-Johns Hopkins University, Kampala, Uganda. Hauptthemen laut MEDLINE: Anti-HIV Agents, Counseling, HIV Infections, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, NIAID NIH HHS, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Adolescent girls and young women (AGYW) account for two‐thirds of new HIV infections in Africa. African AGYW have had high uptake of oral HIV pre‐exposure prophylaxis (PrEP) but low adherence, which might be improved by point‐of‐care adherence monitoring with tailored counselling.

Methods

From August 2022 to July 2023, we conducted a PrEP demonstration project with sexually active AGYW ages 16−30 years from 20 sites in South Africa, Eswatini, Kenya, Malawi, Uganda and Zambia. Participants were offered oral tenofovir‐based PrEP at enrolment and followed up at 1, 3 and 6 months. PrEP adherence was assessed by a point‐of‐care qualitative lateral flow urine tenofovir (TFV) assay indicating PrEP use in the prior 4 days, which accompanied real‐time adherence counselling that incorporated urine TFV results when testing was available (70.8% of month 1, 35.3% of month 3 and 83.9% of month 6 visits). We estimated overall adherence, correcting for missing test results, and analysed the association of having received urine TFV results at month 1 or 3 with subsequent urine TFV test positivity, using modified Poisson regression.

Results

Of the 3087 AGYW enrolled, the median age was 24 years (interquartile range 21−27), 75.7% were from South Africa, 2878 (93.2%) initiated PrEP at enrolment and 107 (3.5%) after enrolment. Visit retention was 92.0−96.2% for months 1, 3 and 6, and 2518 (90.1%) exited the study with a PrEP refill. Adherence, based on the point‐of‐care urine tenofovir test positivity rate, was estimated as 72%, 71% and 65% at months 1, 3 and 6, respectively. Women who received one prior urine TFV test had a 42% higher likelihood of a subsequent positive urine TFV test (adjusted odds ratio, OR = 1.42, 95% confidence interval, CI 1.27−1.60), and those having received two prior tests had a 67% higher likelihood (adjusted OR = 1.67; 95% CI 1.41−1.98). Observed HIV incidence was 1.38/100 person‐years (95% CI 0.97−2.08).

Conclusions

Oral PrEP uptake, recent adherence and persistence were high in a multisite cohort of young African women over 6 months of follow‐up. The use of a novel point‐of‐care tenofovir assay with tailored real‐time adherence counselling was associated with increased adherence to PrEP at subsequent visits, warranting further study. Clinical trials registration clinicaltrials.gov NCT05746065

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsCounselingHIV InfectionsPre-Exposure ProphylaxisTenofovirDrug MonitoringAdolescentAdultFemaleHumansYoung AdultCohort StudiesPoint-of-Care SystemsPoint-of-Care Testing

Stichwörter der Autor:innen

AfricaPrEPadherencepoint‐of‐caretenofovirwomen

Substanzen

Anti-HIV AgentsTenofovir

Autor:innen und Institutionen

  • Makerere University-Johns Hopkins University, Kampala, Uganda.
  • Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Setshaba Research Centre, Pretoria, South Africa.
  • Kenya Medical Research Institute, Nairobi, Kenya.
  • Perinatal Research HIV Research Unit, Soweto, South Africa.

ORCID-Profile: Harriet Nuwagaba-Biribonwoha, Katherine Gill, Alastair vanHeerden, Sinead Delany-Moretlwe, Susan Morrison, Monica Gandhi, Jennifer Velloza, Renee Heffron, Connie Celum

Förderung

  • Gates Foundation
  • NIAID NIH HHS
  • Bill and Melinda Gates Foundation

Zitieren

APA

Gati Mirembe, B., Donnell, D., Krows, M., Zwane, Z., Bukusi, E., Panchia, R., Louw, C., Mwelase, N., Selepe, P., Senne, M., Naidoo, L., Chihana, R., Kasaro, M., Nuwagaba-Biribonwoha, H., Kotze, P., Gill, K., MacDonald, P., vanHeerden, A., Bosman, S., …, & INSIGHT Study Team (2024). High recent PrEP adherence with point‐of‐care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26389

Vancouver

Gati Mirembe B, Donnell D, Krows M, Zwane Z, Bukusi E, Panchia R, et al. High recent PrEP adherence with point‐of‐care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort. Journal of the International AIDS Society. 2024. doi:10.1002/jia2.26389

BibTeX
@article{GatiMirembe2024,
  author = {Gati Mirembe, Brenda and Donnell, Deborah and Krows, Meighan and Zwane, Zinhle and Bukusi, Elizabeth and Panchia, Ravindre and Louw, Cheryl and Mwelase, Noluthando and Selepe, Pearl and Senne, Melissa and Naidoo, Logashvari and Chihana, Rachel and Kasaro, Margaret and Nuwagaba-Biribonwoha, Harriet and Kotze, Philip and Gill, Katherine and MacDonald, Pippa and vanHeerden, Alastair and Bosman, Shannon and Jaggernath, Manjeetha and du Preez, Phillip and Ward, Amy and Peters, Remco P H and Delany-Moretlwe, Sinead and Peacock, Sue and Johnson, Rachel and Caucutt, Jason and Morrison, Susan and Wang, Guohong and Gandhi, Monica and Velloza, Jennifer and Heffron, Renee and Celum, Connie and INSIGHT Study Team, INSIGHT Study Team},
  title = {High recent PrEP adherence with point‐of‐care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort},
  journal = {Journal of the International AIDS Society},
  year = {2024},
  doi = {10.1002/jia2.26389}
}
Kostenlos starten →